LONDON--(BUSINESS WIRE)--The cardiac ablation market is poised to grow by USD 1.77 billion during 2020-2024 progressing at a CAGR of almost 8% during the forecast period.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis
The report on the cardiac ablation market provides a holistic update with market size, forecasts of the trends, growth drivers, and challenges, as well as a detailed vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of cardiac diseases.
The cardiac ablation market analysis includes product and geography landscape. This study identifies transforming marketing and sales strategies for cardiac ablation as one of the prime reasons driving the cardiac ablation market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters
The cardiac ablation market covers the following areas:
Cardiac Ablation Market Sizing
Cardiac Ablation Market Forecast
Cardiac Ablation Market Analysis
Companies Mentioned
- Abbott Laboratories
- AngioDynamics Inc.
- AtriCure Inc.
- Boston Scientific Corp.
- CONMED Corp.
- DVx Inc.
- Imricor Medical Systems Inc.
- Johnson & Johnson
- Medtronic Plc
- Olympus Corp.
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Cardiac ablation catheters - Market size and forecast 2019-2024
- Cardiac ablation devices - Market size and forecast 2019-2024
- Market opportunity by Product
Market Segmentation by Procedure
- Market segments
Market Segmentation by End-user
- Market segments
Customer Landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- AngioDynamics Inc.
- AtriCure Inc.
- Boston Scientific Corp.
- CONMED Corp.
- DVx Inc.
- Imricor Medical Systems Inc.
- Johnson & Johnson
- Medtronic Plc
- Olympus Corp.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.